Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An eye on insulin.

Sarah K Bronson1, Chad E N Reiter, Thomas W Gardner

  • 1Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, Pennsylvania 17033, USA.

The Journal of Clinical Investigation
|June 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetic Retinal Disease Beginning in Childhood.

JAMA ophthalmology·2026
Same author

Diabetic retinal disease: A sensory neuropathy.

Handbook of clinical neurology·2026
Same author

Diabetic retinal disease cure accelerator: Modernizing staging and endpoints.

Progress in retinal and eye research·2026
Same author

Retinal Neurophysiological Parameters in Young Patients With Type 1 Diabetes.

Investigative ophthalmology & visual science·2026
Same author

Diabetic retinal disease.

Nature reviews. Disease primers·2025
Same author

Report of the 2023 Mary Tyler Moore Vision Initiative Workshop.

Translational vision science & technology·2025
Same journal

Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults.

The Journal of clinical investigation·2026
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
See all related articles

Diabetic retinopathy causes vision loss by damaging the retina. Insulin and IGF-1 signaling pathways are key contributors to retinal neovascularization in this condition.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic retinopathy is a leading cause of vision loss and a frequent complication of diabetes.
  • It involves progressive vascular and neural damage within the retina.

Discussion:

  • Insulin and Insulin-like Growth Factor-1 (IGF-1) signaling pathways play a significant role in the pathogenesis of diabetic retinopathy.
  • These pathways modulate the expression of critical vascular mediators, influencing retinal neovascularization.

Key Insights:

  • The study highlights the specific contribution of insulin and IGF-1 signaling to the development of new blood vessels in the retina.
  • Understanding these molecular mechanisms is crucial for targeted therapeutic interventions.

Outlook:

Related Experiment Videos

  • Further research into insulin and IGF-1 signaling could lead to novel treatments for diabetic retinopathy.
  • Targeting these pathways may offer a strategy to prevent or slow vision loss in diabetic patients.